Drawing for ENACT

USPTO serial 88461015

ENACT

Reviewed by CopyMark Law Group

Reg. 6214070Status 700Renewal
Filing date
Status date
Registration date
Dec 8, 2020
Examiner
MORENO, PAUL A
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ENACT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Keith Toms, Esq.

Keith Toms, Esq. McCarter & English, LLP265 Franklin StreetBoston, MA 02110United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of cancer; vaccine preparations for use in connection with cancer and oncology; antibodies sold as an ingredient of pharmaceuticals for the treatment of cancer; antibodies for use in the production of active ingredients of pharmaceuticals and vaccines for use in connection with cancer and oncology; biological preparations for human medical diagnostics and analysis for use in the treatment of cancer; medical diagnostic reagents for use in connection with cancer and oncology; clinical medical reagents for use in connection with cancer and oncology; biological preparations for medical and veterinary purposes in connection with the treatment of cancerACTIVE—
042Research and development in the pharmaceutical and biotechnology fields in connection with cancer and oncology; research and development of medicines in the fields of cancer and oncology; scientific and technological services and research and design services in the fields of cancer and oncology; biological research, clinical research and medical research in the fields of cancer and oncology; chemical and biochemical analysis services in the fields of cancer and oncology; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology in connection with cancer and oncology; clinical research in the fields of cancer and oncology; providing medical and scientific research information in the field of pharmaceuticals in connection with cancer and oncology; Research and development services in the field of antibodies for use in connection with cancer and oncologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 31, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 31, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 31, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 31, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 31, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 31, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 8, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 17, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 17, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 17, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 17, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 17, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 1, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 24, 2024ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Dec 8, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 3, 2020DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Oct 27, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 14, 2020IUCNNOTICE OF ALLOWANCE CANCELLED—
Sep 14, 2020D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Jul 14, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 19, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 19, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 29, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 9, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 9, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 9, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 9, 2020ALIEASSIGNED TO LIE—
Apr 1, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 17, 2020GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Mar 17, 2020GNSIINQUIRY TO SUSPENSION E-MAILED—
Mar 17, 2020CNSISUSPENSION INQUIRY WRITTEN—
Sep 3, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 3, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Sep 3, 2019CNSLSUSPENSION LETTER WRITTEN—
Aug 26, 2019DOCKASSIGNED TO EXAMINER—
Aug 21, 2019TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Aug 21, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jun 19, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 8, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance